Correspondence 0001193125-23-028362 from Terns Pharmaceuticals, Inc. (TERN)
Terns Pharmaceuticals, Inc.
Date: Feb. 8, 2023 · CIK: 0001831363 · Accession: 0001193125-23-028362
AI Filing Summary & Sentiment
File numbers found in text: 333-269508
Letter
Terns Pharmaceuticals, Inc.
1065 East Hillsdale Blvd.
Suite
Foster City, California 94404
February 8, 2023
VIA EDGAR SUBMISSION
U.S. Securities and Exchange Commission
Division of Corporation Finance, Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Cindy Polynice
Re:
Terns Pharmaceuticals, Inc. Registration Statement on Form S-3 File No. 333-269508 Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Terns Pharmaceuticals, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-269508), so that it may become effective at 4:00 p.m., Eastern time, on February 10, 2023, or as soon as practicable thereafter, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.
Very truly yours,
TERNS PHARMACEUTICALS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Terns Pharmaceuticals, Inc. 1065 East Hillsdale Blvd. Suite 100 Foster City, California 94404 February 8, 2023 VIA EDGAR SUBMISSION U.S. Securities and Exchange Commission Division of Corporation Finance, Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Cindy Polynice Re: Terns Pharmaceuticals, Inc. Registration Statement on Form S-3 File No. 333-269508 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Terns Pharmaceuticals, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-269508), so that it may become effective at 4:00 p.m., Eastern time, on February 10, 2023, or as soon as practicable thereafter, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. Very truly yours, TERNS PHARMACEUTICALS, INC. By: /s/ Bryan Yoon Name: Bryan Yoon Title: Chief Operating Officer & General Counsel